| Literature DB >> 25726559 |
Clémence Martin1, Pierre-Régis Burgel2, Patricia Lepage3, Claire Andréjak4, Jacques de Blic5, Arnaud Bourdin6, Jacques Brouard7, Pascal Chanez8, Jean-Charles Dalphin9, Gaetan Deslée10, Antoine Deschildre11, Philippe Gosset12, Lhousseine Touqui13, Daniel Dusser1.
Abstract
This article is the summary of a workshop, which took place in November 2013, on the roles of microorganisms in chronic respiratory diseases. Until recently, it was assumed that lower airways were sterile in healthy individuals. However, it has long been acknowledged that microorganisms could be identified in distal airway secretions from patients with various respiratory diseases, including cystic fibrosis (CF) and non-CF bronchiectasis, chronic obstructive pulmonary disease, asthma and other chronic airway diseases (e.g. post-transplantation bronchiolitis obliterans). These microorganisms were sometimes considered as infectious agents that triggered host immune responses and contributed to disease onset and/or progression; alternatively, microorganisms were often considered as colonisers, which were considered unlikely to play roles in disease pathophysiology. These concepts were developed at a time when the identification of microorganisms relied on culture-based methods. Importantly, the majority of microorganisms cannot be cultured using conventional methods, and the use of novel culture-independent methods that rely on the identification of microorganism genomes has revealed that healthy distal airways display a complex flora called the airway microbiota. The present article reviews some aspects of current literature on host-microbe (mostly bacteria and viruses) interactions in healthy and diseased airways, with a special focus on distal airways.Entities:
Mesh:
Year: 2015 PMID: 25726559 DOI: 10.1183/09059180.00011614
Source DB: PubMed Journal: Eur Respir Rev ISSN: 0905-9180